Ecolab Stock Earnings Reports

Q1 2026 highlights: Ecolab delivered a strong quarter with adjusted diluted EPS up ~13% and organic sales +4% (value pricing +3%, volumes +1%). Operating income margin expanded 70 bps to 16.8% driven by pricing, SG&A productivity and strength across its growth engines. Key growth engines: Global High‑Tech and digital grew >20%, Life Sciences +11% (bioprocessing >100% in Q1), Pest Elimination +7%. Management reiterated full‑year adjusted diluted EPS growth guidance of 12%–15% (excluding short‑term CoolIT impact). Near‑term headwinds: commodity/energy cost inflation (management cites ~9% commodity cost increase expected in Q2) and geopolitical disruption in the Middle East. Actions and outlook: an energy surcharge began April 1 to recover rising energy/commodity costs (management expects to largely offset dollar impact by the end of Q2 and stabilize gross margin in H2). They expect organic sales +6%–7% in H2 (ex‑Ovivo) and continued OI margin expansion toward the 20% target in 2027. M&A and strategic positioning: Ovivo acquisition plus pending CoolIT deal will combine with the existing Global High‑Tech business to form a roughly $1.5B high‑tech franchise (targeting mid/ high‑teens growth for Ovivo; CoolIT reported very strong early‑2026 growth). CoolIT financing and noncash amortization are expected to reduce quarterly EPS by ~$0.20 in the second half of 2026, but management expects the CoolIT contribution and roll‑off of Nalco amortization to neutralize this in 2027. Risks remain around the timing/size of commodity inflation, the Q2 transition quarter, and regulatory/close timing for CoolIT.